Taysha Gene Therapies Inc
NASDAQ:TSHA
Taysha Gene Therapies Inc
NASDAQ:TSHA
Price:
1.72
USD
Market Closed
Market Cap:
352.6m
USD
P/S
Price to Sales
Price to Sales
42.3
Current
24.3
Median
7.3
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=42.3
Market Cap
/
352.5m USD
Revenue
8.3m USD
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
61.2
2-Years Forward
P/S
86.6
3-Years Forward
P/S
7.9
You don't have any saved screeners yet
